Literature DB >> 2782927

Vertical transmission of HIV: a prospective study.

J Y Mok1, R A Hague, P L Yap, F D Hargreaves, J M Inglis, J M Whitelaw, C M Steel, O B Eden, S Rebus, J F Peutherer.   

Abstract

Forty nine infants of HIV seropositive women were followed up for a median of 24 months, together with 24 controls. The infection status of 11 index children under 18 months of age was indeterminate; 34 were presumed uninfected while four showed clinical and laboratory evidence of HIV disease. Based on current definitions of HIV infection and excluding children under 18 months old as well as those who had not been studied from birth, two out of 28 children were infected. The estimated rate of maternofetal transmission was therefore 7.1%. In children with proved infection, sequential laboratory data showed that hypergammaglobulinaemia was noted as early as 6 months and often predated clinical signs. This observation, in the presence of non-specific clinical findings, was helpful in alerting the paediatrician to a diagnosis of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2782927      PMCID: PMC1792513          DOI: 10.1136/adc.64.8.1140

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1987-04-24       Impact factor: 17.586

2.  DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells.

Authors:  C Y Ou; S Kwok; S W Mitchell; D H Mack; J J Sninsky; J W Krebs; P Feorino; D Warfield; G Schochetman
Journal:  Science       Date:  1988-01-15       Impact factor: 47.728

3.  Vertical transmission of HIV in 15-week fetus.

Authors:  S Sprecher; G Soumenkoff; F Puissant; M Degueldre
Journal:  Lancet       Date:  1986-08-02       Impact factor: 79.321

4.  LAV/HTLV-III in 20-week fetus.

Authors:  E Jovaisas; M A Koch; A Schäfer; M Stauber; D Löwenthal
Journal:  Lancet       Date:  1985-11-16       Impact factor: 79.321

5.  Transplacental transmission of HTLV-III virus.

Authors:  N Lapointe; J Michaud; D Pekovic; J P Chausseau; J M Dupuy
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245

6.  Human T-cell lymphotropic virus type III (HTLV-III) embryopathy. A new dysmorphic syndrome associated with intrauterine HTLV-III infection.

Authors:  R W Marion; A A Wiznia; G Hutcheon; A Rubinstein
Journal:  Am J Dis Child       Date:  1986-07

7.  Acquired immunodeficiency syndrome in infants.

Authors:  G B Scott; B E Buck; J G Leterman; F L Bloom; W P Parks
Journal:  N Engl J Med       Date:  1984-01-12       Impact factor: 91.245

8.  Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers.

Authors:  A Rubinstein; M Sicklick; A Gupta; L Bernstein; N Klein; E Rubinstein; I Spigland; L Fruchter; N Litman; H Lee; M Hollander
Journal:  JAMA       Date:  1983-05-06       Impact factor: 56.272

9.  Pregnancies resulting in infants with acquired immunodeficiency syndrome or AIDS-related complex: follow-up of mothers, children, and subsequently born siblings.

Authors:  H Minkoff; D Nanda; R Menez; S Fikrig
Journal:  Obstet Gynecol       Date:  1987-03       Impact factor: 7.661

10.  Immune deficiency syndrome in children.

Authors:  J Oleske; A Minnefor; R Cooper; K Thomas; A dela Cruz; H Ahdieh; I Guerrero; V V Joshi; F Desposito
Journal:  JAMA       Date:  1983-05-06       Impact factor: 56.272

View more
  12 in total

Review 1.  Sexually transmitted diseases in children: HIV infection.

Authors:  J Y Mok
Journal:  Genitourin Med       Date:  1992-10

2.  HIV infection in children.

Authors:  J Mok
Journal:  BMJ       Date:  1991-04-20

3.  HIV-1 infection and perinatal mortality in Zimbabwe.

Authors:  C G Aiken
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

4.  Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor.

Authors:  D A Dibbern; G W Glazner; I Gozes; D E Brenneman; J M Hill
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

5.  Prognostic value of immunological data, in vitro antibody production, and virus culture in vertical infection with HIV-1.

Authors:  M C García Rodriguez; I Bates; I de José; F Hawkins; R Martinez-Zapico; A Ferreira; G Fontán
Journal:  Arch Dis Child       Date:  1995-06       Impact factor: 3.791

6.  Repeated polymerase chain reaction complementary to other conventional methods for early detection of HIV infection in infants born to HIV-infected mothers.

Authors:  C Rudin; H P Senn; R Berger; T Kühne; P Erb
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-03       Impact factor: 3.267

7.  Maternal HIV and drug use: effect on health and social morbidity.

Authors:  J Y Mok; A Ross; G Raab; B Hamilton; S Gilkison; F D Johnstone
Journal:  Arch Dis Child       Date:  1996-03       Impact factor: 3.791

8.  Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection.

Authors:  M C Aldhous; K C Watret; J Y Mok; A G Bird; K S Froebel
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

9.  Early diagnosis of severe combined immunodeficiency syndrome.

Authors:  R A Hague; S Rassam; G Morgan; A J Cant
Journal:  Arch Dis Child       Date:  1994-04       Impact factor: 3.791

10.  Maternal HIV infection, drug use, and growth of uninfected children in their first 3 years.

Authors:  A Ross; G M Raab; J Mok; S Gilkison; B Hamilton; F D Johnstone
Journal:  Arch Dis Child       Date:  1995-12       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.